![Asia Pacific Diagnostic Imaging Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality [X-ray, Computed Tomography, Endoscopy, Ultrasound, Magnetic Resonance Imaging, Nuclear Imaging, Mammography, and Other], Application, and End User- Product Image](http://www.researchandmarkets.com/product_images/12348/12348163_500px_jpg/asia_pacific_diagnostic_imaging_market.jpg)
The diagnostic imaging market in Asia Pacific is expected to grow from US$ 7,818.99 million in 2021 to US$11,572.58 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028.
Artificial intelligence helps improve numerous aspects of the healthcare industry, and diagnostic imaging technique is one of the fields that would benefit greatly. Diagnostic imaging equipment manufacturers worldwide are integrating AI into their products. For example, in September 2018, Nvidia announced launching the Nvidia Clara platform, a combination of software and hardware in diagnostic imaging equipment. Such ground-breaking technology can address the challenges of medical instruments and process enormous amounts of data generated every second that doctors and scientists can easily interpret. Additionally, in August 2018, Google's DeepMind announced launching an AI system that can quickly detect over 50 eye disorders using routine medical scans. DeepMind's AI assistant for diagnostic imaging can automatically tackle eye-related issues by identifying disease symptoms within seconds and prioritizing patients who seek urgent care. AI supportive diagnostic imaging equipment play a vital role in diagnosing and classifying cancers. AI plays a pivotal role in the automated recognition of features from sample medical images while performing diagnostic imaging tasks. For example, automated AI applications enhance clinicians' qualitative potentials, including detection of numerous tumor lesions at a time among patients, prediction of the resultant tumor by referring to the various databases within a short period, translation of phenotypic variations to genotypic, and persistent monitoring of patients. Further, AI generalizes disease imaging techniques with minimal errors resulting in an earlier and more significant diagnosis of diseases.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific diagnostic imaging market at a substantial CAGR during the forecast period.
Artificial intelligence helps improve numerous aspects of the healthcare industry, and diagnostic imaging technique is one of the fields that would benefit greatly. Diagnostic imaging equipment manufacturers worldwide are integrating AI into their products. For example, in September 2018, Nvidia announced launching the Nvidia Clara platform, a combination of software and hardware in diagnostic imaging equipment. Such ground-breaking technology can address the challenges of medical instruments and process enormous amounts of data generated every second that doctors and scientists can easily interpret. Additionally, in August 2018, Google's DeepMind announced launching an AI system that can quickly detect over 50 eye disorders using routine medical scans. DeepMind's AI assistant for diagnostic imaging can automatically tackle eye-related issues by identifying disease symptoms within seconds and prioritizing patients who seek urgent care. AI supportive diagnostic imaging equipment play a vital role in diagnosing and classifying cancers. AI plays a pivotal role in the automated recognition of features from sample medical images while performing diagnostic imaging tasks. For example, automated AI applications enhance clinicians' qualitative potentials, including detection of numerous tumor lesions at a time among patients, prediction of the resultant tumor by referring to the various databases within a short period, translation of phenotypic variations to genotypic, and persistent monitoring of patients. Further, AI generalizes disease imaging techniques with minimal errors resulting in an earlier and more significant diagnosis of diseases.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific diagnostic imaging market at a substantial CAGR during the forecast period.
Asia Pacific Diagnostic Imaging Market Segmentation
The Asia Pacific diagnostic imaging market is segmented based on modality, application, end user, and country.- Based on modality, the market is segmented into X-ray, computed tomography, endoscopy, ultrasound, magnetic resonance imaging (MRI), nuclear imaging, mammography, and others. In 2021, the computed tomography segment held the largest share of the market. It is also expected to register the highest CAGR during the forecast period.
- Based on application, the Asia Pacific diagnostic imaging market is segmented into cardiology, oncology, neurology, orthopedics, gastroenterology, obstetrics/gynecology, and others. The cardiology segment held the largest market share in 2021, and the oncology segment is expected to register the highest CAGR during the forecast period.
- Based on end user, the market is segmented into hospitals and clinics, diagnostic imaging centers, ambulatory surgical centers (ASCs), and others. In 2021, the hospitals and clinics segment held the largest market share. However, the diagnostic imaging centers segment is expected to register the highest CAGR during the forecast period.
- Based on country, the Asia Pacific diagnostic imaging market is segmented into China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. In 2021, China held the largest market share. It is also expected to register the highest CAGR during the forecast period.
Table of Contents
1. Introduction
3. Research Methodology
4. Asia Pacific Diagnostic Imaging Market Landscape
5. Asia Pacific Diagnostic Imaging Market - Key Market Dynamics
6. Asia Pacific Diagnostic Imaging Market Analysis
7. Asia Pacific Diagnostic Imaging Market Revenue and Forecasts to 2028- by Modality
8. Asia Pacific Diagnostic Imaging Market Revenue and Forecasts to 2028 - By Application
9. Asia Pacific Diagnostic Imaging Market Revenue and Forecasts to 2028 - End User
10. Asia Pacific Diagnostic Imaging Market Revenue and Forecasts to 2028 - Country Analysis
11. Asia Pacific Diagnostic Imaging Market -Industry Landscape
12. Company Profiles
13. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- General Electric Company
- Siemens Healthineers
- Koninklijke Philips N.V.
- KARL STORZ SE & Co. KG
- FUJIFILM Holdings Corporation
- Canon Inc.
- Hologic, Inc.
- Carestream Health Inc.
- Stryker Corporation
- Olympus Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 177 |
| Published | September 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 7818.99 Million |
| Forecasted Market Value ( USD | $ 11572.58 Million |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Asia Pacific |
